Search
Descriptor English: Ceftizoxime
Descriptor Spanish: Ceftizoxima
Descriptor Portuguese: Ceftizoxima
Descriptor French: Ceftizoxime
Entry term(s): Cefizox
Ceftizoxime Monosodium Salt
Ceftizoxime Sodium
FK 749
FK-749
FK749
FR 13749
FR-13749
FR13749
Monosodium Salt, Ceftizoxime
SK&F 88373 2
SK&F 88373-2
SK&F 883732
SKF 88373
SKF-88373
SKF88373
Salt, Ceftizoxime Monosodium
Sodium, Ceftizoxime
Tree number(s): D02.065.589.099.249.190.190.145
D02.886.665.074.190.190.145
D03.633.100.300.249.190.190.145
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D015296
Scope note: A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Anti-Bacterial Agents
Registry Number: C43C467DPE
CAS Type 1 Name: 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, (6R-(6alpha,7beta(Z)))-
Previous Indexing: Cefotaxime/analogs & derivatives (1982-1988)
Cephalosporins (1979-1981)
Public MeSH Note: 89
History Note: 89
DeCS ID: 23579
Unique ID: D015296
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1989/01/01
Date of Entry: 1988/05/24
Revision Date: 2017/05/24
Ceftizoxime - Preferred
Concept UI M0023550
Scope note A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
Preferred term Ceftizoxime
Ceftizoxime Sodium - Narrower
Concept UI M0351052
Preferred term Ceftizoxime Sodium
Entry term(s) Ceftizoxime Monosodium Salt
Monosodium Salt, Ceftizoxime
Salt, Ceftizoxime Monosodium
Sodium, Ceftizoxime
SKF-88373 - Narrower
Concept UI M0023554
Preferred term SKF-88373
Entry term(s) SKF 88373
SKF88373
FR-13749 - Narrower
Concept UI M0023552
Preferred term FR-13749
Entry term(s) FR 13749
FR13749
SK&F 88373-2 - Narrower
Concept UI M0023553
Preferred term SK&F 88373-2
Entry term(s) SK&F 88373 2
SK&F 883732
Cefizox - Narrower
Concept UI M0023555
Preferred term Cefizox
FK749 - Narrower
Concept UI M0023551
Preferred term FK749
Entry term(s) FK 749
FK-749



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey